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ABSTRACT 
Obstructive sleep apnea (OSA) is a widely prevalent chronic disease estimated to affect 22 
million Americans, with 80 percent of moderate to severe cases undiagnosed (American Sleep 
Apnea Association [ASAA], 2017). Unmanaged OSA has been associated with numerous 
detrimental health outcomes including hypertension, chronic heart failure, atrial fibrillation, 
stroke, and other cardiovascular conditions (ASAA, 2017). The purpose of this evidence-based 
practice project was to determine if the implementation of a screening protocol would affect 
providers’ adherence to screening for OSA. The Theory of Planned Change was used as a 
guide to optimize providers’ adherence to the protocol at a family medicine clinic in Northwest 
Indiana. Following an extensive review of the literature, the screening protocol was designed 
instructing providers’ which patients needed to be screened for OSA and the preferred method. 
To determine if the screening protocol had an effect on providers’ adherence to screening, a 
two-group comparison design was utilized. Pre-intervention group data were manually collected 
from medical records of at-risk patients at the clinic prior to protocol implementation. Post-
intervention group data were collected from medical records of patients managed after protocol 
implementation. In the pre-intervention group, 1 (0.7%) patient at-risk for OSA were screened 
compared to the post-intervention group 44 (34.9%). Using chi-square test, a significant 
association was found between providers’ adherence to screening at-risk patients between the 
groups (X2(1)=56.67, p<0.001). A significant association was found between providers’ 
adherence to using the STOP-Bang Questionnaire between the two groups (X2(1)=60.61, 
p<0.001). No significant relationship was found between the number of patients referred for 
OSA diagnostic testing between the two groups (X2(1)=.488, p=.485). Although the intervention 
significantly improved providers’ adherence to screening for OSA, clinical significance is limited 
since there was no significant relationship found in the number of patients referred for diagnostic 
testing or incidence of patients with a new diagnosis of OSA.  
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CHAPTER 1 
INTRODUCTION 
Background 
Obstructive sleep apnea (OSA) is a widely prevalent chronic disease often requiring 
lifelong treatment and evaluation. Among sleep-related breathing disorders, OSA is the most 
common (Strohl, 2018). OSA places patients at higher risk of numerous adverse health 
outcomes with severe OSA associated with increased all-cause mortality (Strohl, 2018). Despite 
the severity of health detriments attributed to OSA, the disease is largely undetected and 
undervalued. It has been estimated that 22 million Americans are affected with OSA, with 80 
percent of moderate to severe cases undiagnosed (American Sleep Apnea Association [ASAA], 
2017). It is estimated that 20-30% of males and 10-15% of females in North America have OSA 
(Strohl, 2018).  
As detailed by Greenough and Judd (2017), OSA is a medical condition characterized by 
repetitive apneic episodes, which entails cessation of breathing for varying periods of time 
during the patient’s sleep. Airway blockage is caused when the tongue mechanically collapses 
against the soft palate causing the soft palate to collapse against the throat. Evidence suggests 
that when a patient experiences an occlusive episode, it leads to a disturbance of blood gas 
exchanges such as decreased oxygen saturation and hypercapnia, prompting central nervous 
system (CNS) arousal (Javaheri et al., 2017; Strohl, 2018). This cycle of obstruction and CNS 
stimulation can occur numerous times throughout a patient’s sleep. There are numerous 
detrimental health outcomes associated with OSA either as a consequence of the disorder or as 
a result of not receiving proper management. According to the American Sleep Apnea 
Association (2017), untreated moderate to severe cases of OSA have the potential to lead to 
high blood pressure, chronic heart failure, atrial fibrillation, stroke, and other cardiovascular 
conditions (American Sleep Apnea Association [ASAA], 2017). Considering the current 
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disproportionate state of OSA diagnosis and the potentially dangerous implications of not 
detecting OSA, this is a clinical problem that demands attention.  
Statement of the Problem 
Due to the many health detriments independently associated with OSA, a significant 
amount of research has been conducted focusing on identifying and managing OSA. An 
estimated 80% of moderate to severe OSA is undiagnosed and a majority of primary care 
providers are not regularly screening for OSA demonstrating a large undervaluing of the severity 
of the condition (ASAA, 2017). The Centers of Disease Control (CDC) asserts that despite 
major health contributions attributed to sleep problems, sleep disorders are rarely addressed or 
evaluated by providers during routine visits (Centers of Disease Control [CDC], 2017). It has 
been estimated that only 20% of patients with sleep-related symptoms regularly visiting a 
primary care physician spontaneously self-report their symptoms to their clinician (Jonas et al., 
2017). With the insignificant number of patients disclosing sleep-related problems, it is the 
responsibility of the primary care provider to initiate screening for OSA  to recommended 
patients.  
Data from the Literature  
Attributing to the significance of the project, unmanaged OSA is closely associated with 
numerous pervasive health detriments. Strohl (2018) described the strong associations between 
unmanaged OSA and metabolic syndrome, type 2 diabetes, depression, and traffic accidents. 
Although the association of type 2 diabetes and OSA can be attributed to the shared risk factor 
of obesity, their independent relationship has been supported in several large studies 
suggesting OSA’s potential to exacerbate patients cardiometabolic risk. Postulations of the 
underlying mechanism of these relationships include the repeated apneic episodes and 
increased sympathetic arousal triggering an oxidative stress, vascular endothelial dysfunction, 
and increased platelet adhesiveness (Strohl, 2018). Daytime sleepiness is a common feature in 
patients with OSA and has been associated with impaired daily functioning, cognitive 
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dysfunction, decreased quality of life, and increased frequency of motor vehicle accidents. 
Furthermore, a two-fold increased prevalence of depression as well as sexual dysfunction has 
been demonstrated among patients with OSA (Strohl, 2018). 
Strohl (2018) also addresses prominent risk factors of OSA including advanced age, 
male gender, obesity, and certain craniofacial structures that may occlude breathing. Strohl 
(2018) described that although OSA is present in pediatric populations, the prevalence 
increases in young adults and peaks in the seventh decade of life. Occurrence is also noted to 
be 2-3 times more common in males than females with the gap narrowing after the onset of 
menopause. African Americans younger than 35 years old have a higher incidence of OSA as 
compared to Caucasians of the same demographics. Tufik, Santos-Silvia, Taddei, and 
Bittencourt (2010) performed a study that demonstrated an increased risk for OSA with 
increasing BMI. The findings showed moderate to severe OSA was present in 11% of patients 
with normal weight, 21% in those overweight, and 63% of those that were obese. Additionally, 
findings from a four-year longitudinal study of nearly 700 adults by Peppard et al. (2000) 
reported a six-fold increase of OSA prevalence with a 10% weight increase. Craniofacial 
abnormalities such as short maxillary size, a wide craniofacial base, and tonsillar/adenoid 
hypertrophy increases the risk of OSA (Strohl, 2018). 
There are numerous clinical signs and symptoms associated with OSA. Common patient 
reported symptoms include daytime sleepiness, morning headache, and snoring. Also, patients 
bed partner may complain of patient snoring, gasping, snorting, or interruptions of breathing 
during their sleep (Kline 2018; Strohl, 2018). Snoring has been associated with a sensitivity and 
specificity of 80-90% and less than 50% respectively (Kline, 2018). Strohl (2018) asserts that 
the most useful individual finding for OSA is report of nocturnal choking or gasping with a 
sensitivity of 52% and specificity of 84%. Common clinical exam signs indicating OSA include 
obesity (BMI >30 kg/m2), narrow oropharyngeal airway (classified as a modified Mallampati 
score of 3 or 4), large neck circumference (>17 in. in males and >16 inches in females) and 
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hypertension (Kline 2018; Strohl, 2018). Markedly, it is estimated that half of patients with OSA 
have coexisting hypertension (Kline, 2018). Patient symptoms should be evaluated in context 
with physical signs observed. For example, patients with report of snoring and a BMI of < 26 are 
less likely to have moderate to severe OSA (Kline, 2018).  
Given the varying efficacy of independent patient signs and symptoms, several clinical 
screening tools have been developed to aid in OSA identification. Common screening tools 
include Epworth Sleepiness Scale (ESS), STOP questionnaire (SQ), STOP-BANG 
questionnaire (SBQ), Sleep Apnea Score (SACS), Berlin Questionnaire (BQ), and Multivariable 
Apnea Prediction instrument (MVAP) (Kline, 2018). These clinical tools often combine patient 
symptoms with common physical exam findings to generate a score that is correlated with the 
patient’s risk of OSA. For example, the letters of STOP-Bang represent an acronym consisting 
of snoring, tiredness, observed apneas, blood pressure, BMI, age, neck circumference, and 
gender (Kline, 2018). Each positive finding associated with the acronym letter delineates a point 
with scores of greater than three of eight indicating possible OSA (Kline, 2018).  Because many 
screening tools were developed using known high-risk patient population settings such as sleep 
clinics, they are often less useful in their ability to screen asymptomatic patients. While there is 
currently no established gold standard screening tool that is widely endorsed or recommended, 
several studies have compared the sensitivity and specificity of each tool allowing an informed 
clinical judgement to be made by the provider. As established by Kline (2018), the SBQ 
frequently demonstrates the highest sensitivity in detecting OSA when compared to other 
screening questionnaires in high-risk patients. This was further supported in a cross-sectional 
observational study by Miller et al. (2018) comparing multiple screenings tools sensitivity of 
predicting OSA. The study concluded the STOP-Bang questionnaire demonstrated the highest 
sensitivity of OSA among at-risk patients and was the desirable tool to use in screening (Miller 
et al., 2018). 
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The diagnosis of OSA is confirmed by either in-laboratory polysomnography or home 
sleep apnea testing (HSAT). In-laboratory polysomnography is considered the gold standard to 
diagnosis OSA and is preferred in patients with suspected complicated OSA such as those with 
comorbidities, those suspected to have other sleep disordered breathing conditions, and 
suspected mild OSA (Kline, 2018). HSAT is considered appropriate in patients suspected to 
have moderate to severe uncomplicated OSA (Kline, 2018). Patient preference and 
environmental factors should be taken into consideration regarding which method of diagnostic 
testing is selected. Although in-laboratory testing is the gold standard, many HSAT devices 
have been validated against standard polysomnography (Kline, 2018). Diagnosis is confirmed 
via in-laboratory testing or HSAT, observing the frequency of observed apneas, hypopnea, and 
respiratory effort-related arousals (Kline, 2018). At least five obstructive respiratory events per 
hour of sleep must be noted in addition to the presence of one or more of the following: 
sleepiness, nonrestorative sleep, fatigue, or insomnia symptoms; waking up with breath holding, 
gasping or choking; habitual snoring, breathing interruptions, or bother noted by partner or 
observer; hypertension, mood disorder, cognitive dysfunction, coronary artery disease, stroke, 
congestive heart failure, atrial fibrillation, or type 2 diabetes mellitus. Additionally, the 
occurrence of 15 or more obstructive respiratory events per hour of sleep regardless of 
associated symptoms confirms the diagnosis of OSA (Kline, 2018).   
Kline (2018) explains that patients with OSA are classified in regard to severity of the 
disorder based on the frequency of respiratory events per hour referred to as the apnea-
hypopnea index (AHI) detected by either in-laboratory polysomnography or HSAT. Respiratory 
events monitored include apneas from total occlusions, hypopneas from partial occlusions, 
mixed apneas, or respiratory related arousals. An AHI score is generated using the average 
number of apneas plus hypopneas per hour of sleep. Mild OSA encompasses those with an AHI 
between 5-14 events per hour, moderate 15-29, and severe greater than or equal to 30.  
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Once an OSA diagnosis is confirmed, management should be immediately initiated due 
to the chronic long-term nature of the condition. There are numerous treatment options available 
for OSA including positive airway pressure methods, oral appliances, and surgical treatment 
such as airway reconstruction as well as adjunct therapy options including weight loss and 
bariatric surgery (Epstein et al., 2009). The gold standard of treatment for mild, moderate, and 
severe OSA is continuous positive airway pressure (CPAP) and should be recommended to 
each patient (Epstein et al., 2009). A summary of the evidence concluded that the use of CPAP 
for treating OSA effectively reduced the patients AHI to normal ranges or near normal ranges 
(Bibbins-Domingo et al., 2017). Furthermore, studies have demonstrated a reduction of blood 
pressure and improved sleep quality associated with CPAP treatment (Jonas et al., 2017). 
Mandibular advancement devices (MADs) are oral appliances that are often utilized as an 
alternative treatment option for patients unable to tolerate CPAP. MADs were shown to be 
effective with decreasing AHI scores compared to placebo, but no significant blood pressure 
reduction was demonstrated (Jonas et al., 2017). Surgical options such as radiofrequency 
surgery of the soft palate, tissue ablation, uvulopalatopharyngoplasty, septoplasty, and bariatric 
surgery have limited evidence available demonstrating no significant reductions in AHI or blood 
pressure (Jonas et al., 2017). Although current research is sparse on weight loss, diet, and 
exercise as treatment options, the available data depicts an associated AHI reduction with these 
modalities (Jonas et al., 2017).  
Data from the Clinical Agency Supporting Need for the Project 
A local private family practice clinic was selected as the ideal setting to implement this 
project. This family practice clinic consists of a physician, a nurse practitioner, a nutritionist, a 
nurse, two medical assistants, and two front desk secretaries. The site serves a wide variety of 
patients with the majority of patients considered Caucasian and African American. Although the 
site offers services to all ages, the majority of patients are between 20-80 years old. The 
physician has additional training in obesity management and treatment thus complimenting the 
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services provided by the nutritionist. Due to the additional focus and services for obesity and 
weight loss, there is a higher prevalence of patients that are considered overweight and obese 
that utilize the clinic for routine care. Currently there are ambiguous clinic guidelines in regard to 
screening for OSA. The clinic has no established protocol for classifying patients as at-risk for 
OSA necessitating appropriate screening. Screening appears to be performed at random 
primarily by patients self-reporting a suspicion of OSA. Current practice at the clinic also 
demonstrates inconsistencies of which screening tool is used. While the providers report using 
the STOP-Bang questionnaire (SBQ) to screen patients, the clinical staff provides that they use 
the Epworth Sleepiness Scale (ESS) creating ambiguous procedures and inconsistent 
screening.  
Purpose of the Evidence-Based Practice Project 
The goal of evidence-based practice is to promote the use of best practice guidelines 
established by current evidence. The intent of this EBP project was to examine the best-practice 
recommendations of screening for OSA in the primary care setting by developing a policy based 
on current practice guidelines and best evidence. The aim of the project was to implement a 
protocol that broadened the base of patients that were being screened using established criteria 
while using the clinical tool that demonstrated the best sensitivity for detecting OSA. The 
underpinnings of implementing a screening protocol was an effort to attenuate the number of 
patients with undetected OSA that were potentially reaping the adverse effects of unmanaged 
OSA.  
PICOT Question 
The PICOT (patient population, intervention of interest, comparison intervention, 
outcome and timeframe) format was used to facilitate the structure of the EBP project. The 
PICOT question examined was, “In the internal medicine setting, how does implementation of a 
revised obstructive sleep apnea screening protocol affect providers’ adherence to screening 
over a one-month period as compared to current practice?”. 
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Significance of the Problem 
Enhancing screening for OSA allows for earlier treatment and intervention with the goal 
of preventing adverse health outcomes associated with untreated OSA. Aurora and Quan 
(2016) support the impact of optimal screening stating, “since treatment of OSA has been 
shown to improve cardiovascular outcomes, screening for OSA in known high-risk populations 
has merit” (Aurora & Quan, 2016, p. 1186). As mentioned, OSA has been associated with 
several health consequences when left untreated such as hypertension, stroke, type 2 diabetes, 
and depression which are some of the leading causes of morbidity and mortality (Aurora & 
Quan, 2016; Strohl 2018). In addition to the improved patient outcomes, increased screening 
and treatment of OSA would signify a reduction in national health care cost. Individuals with 
untreated OSA are estimated to accumulate between 34 to 69 billion dollars in direct health care 
cost per year as a result of the associated significant chronic co-morbidities, decreased quality 
of life, decreased workplace productivity, motor vehicle and work-place accidents (American 
Academy of Sleep Medicine [AASM], 2016; Aurora & Quan, 2016). By enhancing providers’ 
adherence to screening for OSA, this would promote a shift in the delivery of care by 
emphasizing primary and secondary prevention potentially resulting in improved patient 
outcomes and reduction of national healthcare debt.  
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CHAPTER 2 
THEORETICAL FRAMEWORK, EBP MODEL, AND REVIEW OF LITERATURE 
Essential to evidence based-practice (EBP) is the utilization of current best-practice 
evidence to guide in the delivery of high-quality healthcare. A synthesis of varying levels of 
evidence is appraised leading to identification of major concepts as the basis of best-practice. 
Consequently, an exhaustive systematic literature review of best practice was conducted in 
generating a policy related to screening for obstructive sleep apnea (OSA) in the primary care 
setting. A theoretical framework and EBP model were used to guide in the development of this 
project. The purpose of this chapter will be to explore the theory and EBP model utilized to 
guide the established EBP project, as well as detail the literature search conducted. 
Theoretical Framework 
Overview of the Theoretical Framework 
Concepts from Kurt Lewin’s Theory of Planned Change were employed to guide project 
development. Lewin was a prominent social psychologist and sought to assess factors 
influencing behavior as a strategic means to guide change (Shirey, 2013). Lewin’s theory is 
composed of several complimenting micro-theories including the force field analysis, quasi-
stationary equilibria, and the individual-group relationships theory, and serves to explain how 
change occurs at the individual level of those that are involved in the change (Tiffany & Lutjens, 
1998). To provide a brief overview, the force field analysis micro-theory is comprised of three 
stages including unfreezing, moving, and refreezing that provides instruction to guide the 
change process. The quasi-stationary equilibria micro-theory compliments the force-field 
analysis by explaining driving forces and restraining forces that promote or prevent the change 
(Tiffany & Lutjens, 1998). Driving forces are influences that motivate and strengthen the need 
for change while restraining forces hinder or prevent the change (Shirey, 2013). Within the 
theory these forces are depicted as opposing arrows facing each other across a straight line in 
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the middle which represents the equilibrium or state of functioning (Tiffany & Lutjens, 1998). 
Tiffany and Lutjens (1998) explain that the opposing arrows or forces either push the line 
towards the change or away depending on the cumulative strength of the forces. The individual-
group relationships micro-theory concepts explains how the driving and restraining forces are 
developed or changed. Cognitive and affective experiences shape individual values and are 
strengthened during group interactions. These group interactions develop into power fields that 
exert pressure to maintain group standards. By influencing individual’s value formation, this 
manipulates the strength of the forces to either promote or prevent change. Concepts from each 
of these micro-theories can be applied within the stages of change.  
Unfreezing. Shirey (2013) explains the unfreezing stage is characterized by a change 
agent recognizing a problem and identifying the need to change the current equilibrium. 
Communication to key stakeholders regarding the need for change to help facilitate a better 
practice is essential in this stage. After the problem is recognized and changed is desired, 
preparations for the change are initiated by proposing solutions. Paramount to this stage and 
ultimately propelling a successful change is strengthening driving forces and weakening 
restraining forces. This can be accomplished through re-education aimed to alter individuals’ 
values that conforms to the desired change (Tiffany & Lutjens, 1998).    
Moving. Shirey (2013) describes that during this stage members are actively engaged in 
implementing the change. This stage is also known as transitioning and involves the inner 
movement that individuals make in reaction to the change. Inner movement incorporates 
implementation of the selected change.  
Refreezing. In this last stage, the change is stabilized and becomes embedded into the 
new equilibrium (Shirey, 2013). This new equilibrium represents a system change reflected in 
the culture, policies, and practices and should ideally be of higher quality than the original. In a 
successful change, the driving forces accentuating the change continue to outweigh the 
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hindering forces. Often overlooked, refreezing or solidifying the change within the system 
determines the changes sustainability and permanency.  
Application of Theoretical Framework to EBP Project 
Sutherland (2013) demonstrated the applicability and success of employing Lewin’s 
theory in the implementation of a bar-coded medication administration (BCMA) project. The 
unfreezing stage was initiated after identifying a problem with the current medication delivery 
system consisting of old medication carts in disrepair and relying on manual verification that the 
right medication is being correctly administered to each patient. This presented a problem to the 
facility due to the serious risks medication errors present to a patient’s health and safety which 
may result in increased health care cost. This may also have the potential to negatively affect 
nursing morale. The key stakeholders that were most affected by the change were identified as 
staff nurses, managers, and administrators. With a driving force of avoiding risks of medication 
errors the need for change was accepted and solutions were hypothesized, namely a BCMA 
system. Essential to the success of the project was identification of driving and restraining 
forces in the unfreezing stage. Restraining forces included staff members aversion to using 
technology, lack of computer experience, and lack of trust in the organization. Key driving forces 
included staff’s desire to ensure optimal patient safety, ease of use of the proposed medication 
administration system as compared to current medication administration system, and an 
increase satisfaction for staff in relation of better time management of patient care. After 
educating on the severe risks of medication errors, the driving forces were strengthened and 
ultimately outweighed the restraining forces, thus progressing the project to the moving stage. A 
designated project leader was appointed to oversee the implementation of the BCMA 
technology. Multiple disciplines were involved in the implementation of the change to bolster 
acceptance of the proposed change including information technology, pharmacy, and nursing 
staff in an effort to ensure all stakeholders were included in the change. During the final 
refreezing stage of the project, ongoing support with the fully operational new system deemed 
EFFECTS OF  12 
the implementation a success. Implementation of the BCMA system signified a change in the 
equilibrium by creating a system change resulting in a new process of medication administration 
that sought to increase patient safety. Sutherland (2013) depicts Lewin’s Theory of Planned 
Change as being instrumental in the successful implementation of a BCMA system and serves 
as a model to reference for future projects.   
Concepts from Lewin’s Theory of Planned Change applied to the goal of this EBP 
project of establishing a sustainable change of screening for OSA in at-risk patients. The three 
stages of change in Lewin’s theory were essential in the development and implementation of the 
EBP project. The unfreezing stage started with discussion with clinical staff serving as key 
stakeholders about the practice’s current process of screening for obstructive sleep apnea. It 
was openly accepted that the current method of screening for OSA was not consistent as 
evidence by some staff using the Epworth Sleepiness Scale and others using the STOP-Bang 
questionnaire. Furthermore, screening was done at random mainly as a result of patient’s self-
reported suspicion of OSA. The current practice presented a problem as unmanaged OSA has 
the potential to lead to numerous adverse health outcomes to patients. Potential solutions were 
discussed namely the implementation of a screening protocol. By creating an open dialogue, 
restraining forces were identified that could potentially prevent this adoption of the protocol. 
Restraining forces included staffs’ belief that screening for OSA had minimal value, staffs’ 
opinion that screening was time consuming, and that screening was a burden to the patients. 
However, there were several driving forces highlighted during discussed that supported a 
change in practice for screening OSA. Driving forces included staffs’ desire to promote optimal 
patient outcomes while achieving compliance with best practice standards. By providing 
education to staff members on the adverse health outcomes associated with unmanaged OSA, 
this strengthened the driving forces of the staffs’ desire to promote optimal patients’ outcomes 
which outweighed the restraining forces. This symbolized a successful unfreezing stage and 
readiness for the project to enter into the moving stage.  
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The moving stage of the project began with the implementation of the screening 
protocol. Imperative to the long-term sustainability of the project, each stakeholder including 
physician, nurse practitioner, nurse, and medical assistants needed to be educated and actively 
engaged in the implementation. The moving stage consisted of the providers actively engaging 
the protocol into practice by identifying at-risk patients and screening those using the STOP-
Bang questionnaire. This phase represented a shift in the equilibrium as the protocol created a 
change in the workflow process.  
Once the protocol was implemented into current practice, this represented the refreezing 
stage. A new equilibrium is represented by a new way or process for screening OSA embedded 
into the practice of the clinic. Ultimately, follow-up with staff compliance with adhering to the 
protocol will determine if the change was successful in achieving permanency or if driving forces 
no longer continued to outweigh resisting forces.  
Strengths and weaknesses of theoretical framework. Strengths of the theory include 
versatility and practicality. Although the theory was developed in the setting of psychology and 
group dynamics, it has applicability across numerous disciplines including nursing. Sutherland 
(2013) demonstrated the theory’s use in the acute care setting, while others have applied to 
management settings. The theory is best applied in a top-down approach meaning one leader 
serves as a change champion driving the change throughout the organization (Shirey, 2013). 
This theory allows for stable change over time which aligned with the aims of this EBP project.  
Weaknesses identified in the utilization of this theory included the potential for poor long-
term sustainability of the change. The risk for continued adherence is of concern due to the 
change often starting with administration and propelled by a change champion rather than being 
generated by front-line staff implementing the change. The theory is criticized for being too 
linear and simple while change is seen as dynamic and unpredictable. It can be argued that 
change is too complex to be categorized into three stages. 
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Evidence-Based Practice Model  
Overview of EBP Model 
Complementing the Theory of Planned Change, the second edition of the John Hopkins 
Nursing Evidence-Based Practice (JHNEBP) model also served as a guide in the development 
and implementation process of this EBP project. The model was developed in response to 
clinical nurse’s feedback expressing a desire for a process to help facilitate their evaluation and 
application of best evidence into bedside care (Dang et al., 2015).  As a result, this model was 
developed as a means to promote the translation of new knowledge into current practice at 
John Hopkins Hospital after recognizing gaps between the standards of care and the actual 
care provided (Dang et al., 2015).  
Unique to the JHNEBP model is the three phased process used to guide change 
implementation. This process is known as the PET process which represents the three phases 
of practice question, evidence, and translation (Dang et al., 2015). Dang et al. (2015) explains 
that within each of these three phases are multiple prescriptive steps with a total of 18 steps. 
The steps are relevant to each of the three phases and are designed to progress the 
implementation or translation of best evidence into current practice.  
Practice question. Newhouse et al. (2007) explains that the first phase of the EBP 
process is comprised of 5 steps and begins with an interdisciplinary team developing an EBP 
question. The EBP question should be refined into a narrow and specific question using the 
PICOT format. The scope of the question should be defined and should guide identification of 
stakeholders. For example, if the project scope represents a departmental change, members of 
that department need to be informed and involved. An interdisciplinary team should be formed 
with leadership and responsibilities assigned. The first phase of the process is crucial, as the 
developed EBP question drives the remaining process.    
Evidence. The second phase includes 5 steps and encompasses the literature search, 
appraisal, summary, and synthesis of best evidence (Newhouse et al., 2007). Newhouse et al. 
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(2007) explains that this phase begins with a comprehensive literature search incorporating a 
variety of evidence such as research studies, practice guidelines, quality improvement data, and 
opinions of experts. To ensure a thorough search is performed it is recommended to consult a 
health information specialist such as a library search specialist. After the search for evidence is 
complete, the level and quality of evidence should be appraised. The evidence should then be 
grouped together according to the appraised level and summarized. After summarizing the 
evidence, a synthesis of findings should be performed leading to the development of practice 
recommendations. Unique to this model are four pathways that determine how to proceed 
based on the strength of the current evidence (Dang et al., 2015). For example, the first 
pathway recommends that a practice change is implemented since there is consistent high-
quality evidence yielded from the literature search (Dang et al., 2015). On the contrary, the 
fourth pathway suggests a revised literature search for new evidence or discontinuation of the 
project due to little or no available evidence supporting the proposal (Dang et al., 2015). 
Translation. The last phase of the process entails eight steps that guide the 
implementation and evaluation of the EBP project change. Newhouse et al. (2007) explains that 
after evaluating the strength and recommendations from the literature search, the 
interdisciplinary team decides if the change is feasible and appropriate. Once the team agrees 
to proceed with project implementation, an action plan is created, and the change is 
implemented. After implementation, outcomes are evaluated including identification of any 
unexpected findings. The results should then be reported to the stakeholders and discussed if 
the change should be adopted internally depending on the outcomes. Regardless of outcome, it 
is urged that findings are to be disseminated. 
Application of Evidence-Based Practice Model to Project 
The JHNEBP model was instrumental in project development and assimilation of best 
evidence. During the developmental stage of the project, the model was fundamental to ensure 
high-quality evidence was utilized. This created a strong foundation for a successful 
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implementation. The dynamic nature of this model allowed for consideration of internal forces 
such as office culture and staff opinions that had the possibility of hindering the implementation. 
Recognizing these factors and promoting open communication have aided in the smooth 
application of the project.  
The JHNEBP has been applied across numerous settings and initiatives as a tool to 
evaluate EBP. Mori (2015) provides a detailed systematic application of the model in the 
endeavor to decrease methicillin-resistant Staphylococcus aureus (MRSA) surgical site 
infections (SSI) in total knee and hip arthroplasty patients. Mori (2015) begins the JHNEBP 
process by developing the EBP question in PICOT format. Stakeholder support was achieved 
after interdisciplinary team members reached consensus that the current rate of surgical site 
infections posed a problem that needed attention. Roles within the team were delineated and 
the project advanced to the evidence phase of the model. During the second phase Mori (2015) 
provides detail of the literature search and appraisal process. Evidence was appraised and 
synthesized to develop recommendations including the procedure of screening for MRSA before 
surgery, use of chlorhexidine gluconate soap, and the procedure of decolonizing certain patients 
with intranasal antibiotics (Mori, 2015). After the recommendations were developed based on 
reviews of evidence, the translation phase sought to begin the project implementation. 
Feasibility of the implementation was explored including financial burden of the screening 
recommendations compared to the cost savings of reducing SSI’s. Outcomes were evaluated 6 
months after implementation demonstrating reduced SSI rates from 5.3% to 0 (Mori, 2015). 
These results were then disseminated and communicated with other institutions. Mori (2015) 
provides an exemplar application of the JHNEBP model framing the success of introducing best 
evidence into practice leading to positive patient health outcomes.  
The JHNEBP benefitted the EBP development and application of this project. After 
establishing necessity in improving screening for obstructive sleep apnea (OSA) with front-line 
staff and key stakeholders, an exhaustive literature search allowed for the appraisal and 
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summary of the best-evidence. With no established universal recommendations for OSA 
screening, synthesis of multiple evidence findings and reviews guided the development of the 
project protocol recommendations. This project was comprised with clinical guidelines and 
quality measures from the American Sleep Apnea Association (ASAA) and American Academy 
of Sleep Medicine (AASM) as well as numerous other sources that were appraised for quality 
and strength.  
Strengths and weaknesses of the JHNEBP model. Strengths of this model include 
the step-wise approach of best-practice utilization beginning with formulating a PICOT question 
to evaluating and disseminating findings. Distinct to this model is the incorporation of an 
evidence appraisal system and pathway that allows the strength of the literature to determine 
appropriate implementation. Important to this model is the evaluation of the project and 
dissemination of findings thus advancing future initiatives. The JHNEBP has versatility in its 
application in a variety of settings including clinical nursing, administrations, education, and 
advanced nursing practice. As demonstrated in EBP project initiatives, this model has assisted 
in improving patient health outcomes.  
Weaknesses of the model may include the lengthy number of steps comprised in the 
model. With the model’s heavy emphasis on best-evidence, this may diminish the patient 
preferences and provider opinion which are integral to the EBP process. 
Literature Search  
An extensive methodological literature search was performed to ensure the use and 
incorporation of best-practice evidence in screening for obstructive sleep apnea (OSA) in the 
primary care setting. Databases searched included (a) The Cochrane Library, (b) Joanna Briggs 
Institute (JBI), (c) National Guideline Clearinghouse (NGC), (d) Medline via EBSCO, (e) Medline 
via Pub-Med, and (f) Cumulative Index to Nursing and Allied Health Literature (CINAHL). 
Consistent throughout multiple database searches was the use of the medical subject heading 
terms (MeSH) of sleep apnea, obstructive. Uniform keywords across each database were used 
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included obstructive sleep apnea, screening, identify, detect, primary care, family practice and 
clinic. Utilization of truncation in the keywords was employed. Last, citation chasing was 
performed from appropriate sources.  
Search results. Search results yielded for each database is displayed in Table 2.1. 
Majority of databases produced over 50 results with varying degrees of relevance and 
applicability.  
Inclusion and exclusion criteria. Standardized inclusion criteria were utilized and 
included only scholarly peer-reviewed articles that were published within the last 10 years. 
Articles had to be in the English language and the main subject population of adults. Articles 
that were hand-picked from citation chasing were referenced within scholarly articles and 
included general themes of screening for OSA in the primary care setting. Articles were included 
for review if they included OSA screening methods in other settings, but patients in the primary 
care population must be included. Themes of articles that were reviewed included the 
effectiveness of clinical exam findings in detecting for OSA, accuracy of screening tools in 
identifying OSA, and recommendations of patients that should be screened for OSA. 
Exclusion criteria included articles that were published more than 10 years ago. Also, 
articles that only focused on patients in the surgical setting, evidence that examined pediatric 
patients, or articles that focused on pregnant patient populations were not included.  
Levels of evidence. After assessing the relevance of the evidence based on a review of 
the abstract, each article was graded utilizing the Schmidt and Brown (2019) evidence 
hierarchy. The Schmidt and Brown (2019) evidence hierarchy levels evidence from 1-7 with 
Level 1 being the highest quality and Level 7 being the lowest.  The 7 levels of evidence are as 
follows: “1.) Evidence from meta-analysis, systematic reviews of RCTs, and current practice 
guidelines; 2.) Evidence from randomized controlled trails; 3.) Evidence from controlled trials 
without randomization (quasi-experimental); 4.) Evidence from cohort studies (epidemiologic) 
and case-controlled studies (epidemiologic); 5.) Evidence from systematic reviews of descriptive 
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studies, systematic reviews of qualitative studies (meta-analysis), and correlational studies; 6.) 
Evidence from single descriptive studies, single qualitative studies, case series studies 
(epidemiologic), case reports, or concept analysis; 7.) Evidence from the opinion of authorities, 
reports of expert committees, manufacturer's recommendations and traditional literature 
reviews” (Schmidt & Brown, 2019). Included in this project were 9 total articles. Of the nine 
studies one was level 1, six level 5, and two level 7. Evidence was also assigned a quality score 
based on the John Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal 
and Non-Research Evidence Appraisal tools. High quality research is assigned an A quality 
score, good quality research scores B, and low-quality research or major flaws receives a C 
(John Hopkins Nursing Evidence Based Practice, n.d.). Included articles with corresponding 
levels are depicted in Table 2.2. 
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Table 2.1 
 
Studies Obtained from Database 
 
Database Initial Articles 
Yielded 
Duplicates Articles 
Reviewed 
Article 
Accepted 
JBI 38 0 2 0 
Cochrane 14 0 1 0 
CINAHL 78 2 2 0 
MEDLINE 38 11 2 0 
ProQuest 75 7 4 3 
National 
Guideline 
Clearinghouse 
 
32 2 3 2 
Hand Search -  7 4 
Total 275 85 21     9  
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Table 2.2 
 
Levels of Evidence 
 
 
Evidence 
Level 
 
Articles Included Quality  
Level 1 1 C (1) 
Level 2 0  
Level 3 0  
Level 4 0  
Level 5 
Level 6 
6 
0 
A (4), B (2) 
 
Level 7 2 B (1) 
C (1) 
   
Note. Adapted from Schmidt and Brown Evidence-based Practice for Nurses (2019) 
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Table 2.3 
Appraisal of Evidence 
 
Citation Design/ Level Sample/Setting Measurement/ Outcomes Recommendations/ Findings  
 
Rating 
Epstein, L., Kristo, 
D., Strollo, P., 
Friedman, N., 
Malhotra, A., Patil, 
S., . . . Adult 
Obstructive Sleep 
Apnea Task Force 
of the American 
Academy of Sleep 
Medicine. (2009). 
Clinical guideline for 
the evaluation, 
management and 
long-term care of 
obstructive sleep 
apnea in adults. 
Journal of Clinical 
Sleep Medicine, 
5(3), 263-276. 
 
Clinical 
Guideline/  
Level 1 
Included studies 
not stated 
Issue of clinical 
recommendations 
concerning the evaluation, 
management, and long-
term care of OSA in 
adults. 
 
Expert consensus established patient 
populations that should be evaluated 
for OSA during routine health 
maintenance evaluations. Study 
findings showed evaluations should be 
completed on those who reported 
symptoms indicative of OSA, and 
those considered at high risk for OSA. 
Based on three established patient 
populations, those considered at-risk 
should receive a comprehensive sleep 
history and physical. Patients with 
positive findings should then be 
referred for sleep study. 
 
  
C 
 
Jonas, D. E., 
Amick, H. R., 
Feltner, C., Weber, 
R. P., Arvanitis, M., 
Stine, A., . . . Harris, 
R. P. (2017). 
Screening for 
obstructive sleep 
 
Systematic 
Review/Meta-
Analysis 
Level 5  
 
110 studies 
(N=46188) 
RCTs and 
prospective 
cohort studies 
included  
 
Eight key questions with 
evidence rationales 
addressing screening, test 
accuracy, and treatment 
of OSA. 
 
Overall, study concluded that there 
was insufficient evidence in the clinical 
utility and accuracy in universal 
screening of patients. It was 
acknowledged that there are many 
adverse health outcomes associated 
with OSA. Authors discussed with 
multiple management options shown to 
  
A 
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apnea in adults: 
Evidence report and 
systematic review 
for the US 
preventive services 
task 
force. Jama, 317(4), 
415-433. 
doi:10.1001/jama.2
016.19635 
 
reduce apnea-hypopnea index scores 
as well as blood pressure.  
However, no treatment has been 
established proven to reduce mortality. 
Although universal screening is 
currently supported, there is utility in 
identifying and managing patients with 
OSA. 
 
  
 
 
Miller, J. N., & 
Berger, A. M. 
(2015). Screening 
and assessment for 
obstructive sleep 
apnea in primary 
care. Sleep 
Medicine Reviews, 
29, 41-51. 
doi:10.1016/j.smrv.
2015.09.005 
 
 
 
Systematic 
Review/ 
Level 5 
 
 
17 studies (14 
nonexperimental
, 3 experimental) 
 
 
Study reviewed and 
evaluated current 
screening and 
assessment of OSA in the 
primary care setting 
 
 
 
Findings showed that screening for 
OSA should occur in three patient 
categories: any adult reporting 
symptoms of OSA, every patient during 
annual health maintenance, and 
patients that are at high-risk. Signs and 
symptoms triggering further evaluation 
should include snoring, witnessed 
apneas, nocturnal gasping/choking, 
unexplained daytime sleepiness, large 
neck circumference (>17 inches in 
men, >16 inches in women), sleep 
fragmentation/insomnia, and non-
refreshing sleep. High-risk patients 
necessitating screening were defined 
as those with obesity (BMI >35 kg/ 
m2), cardiac or metabolic comorbid 
conditions (congestive heart failure, 
atrial fibrillation, hypertension, type 2 
diabetes, nocturnal cardiac 
dysrhythmias, stroke, and pulmonary 
hypertension), and patients that are 
pre-operative for bariatric surgery.  
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EFFECTS OF  24 
Sensitivity and specificity of multiple 
clinical prediction tools for OSA was 
compared and concluded that the 
STOP-Bang and Berlin questionnaires 
are the current best methods in 
predicting moderate to severe OSA. 
Overall, more research is needed on 
screening for OSA 
 
 
Myers, K. A., 
Mrkobrada, M., & 
Simel, D. L. (2013). 
Does this patient 
have obstructive 
sleep apnea?: The 
rational clinical 
examination 
systematic 
review. Jama, 310(
7), 731-741. 
doi:10.1001/jama.2
013.276185 
 
 
Systematic 
Review/ 
Level 5 
 
42 studies 
Design and 
quality not 
provided  
 
Comparison of patient 
symptoms, clinical signs, 
and screening tools 
accuracy in detecting 
OSA 
 
Review sought to compare the 
accuracy of patient reported  
symptoms clinical sign’s sensitivity and 
specificity in detecting OSA.  
Multiple signs and symptoms were 
compared and snoring was found to 
have highest sensitivity, but lowest 
specificity. Nocturnal choking or 
gasping was determined to be the 
most useful individual subjective 
finding in detecting OSA. Determined 
that there was no one sign or 
symptoms precise enough to rule in or 
out condition. 
Sensitivity and specificity of multiple 
screening questionnaires was 
compared and the  
STOP-Bang questionnaire 
demonstrated the highest sensitivity in 
detecting mild OSA and the 
Snoring Severity Scale had the highest 
sensitivity in detecting moderate OSA. 
 
 
 
B 
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Abrishami, A., M.D., 
Khajehdehi, A., 
M.D., & Chung, F., 
M.D. (2010). A 
systematic review 
of screening 
questionnaires for 
obstructive sleep 
apnea. Canadian 
Journal of 
Anesthesia, 57(5), 
423-38. 
doi:http://dx.doi.org.
ezproxy.valpo.edu/1
0.1007/s12630-010-
9280-x 
 
Systematic 
Review/ 
Level 5 
10 studies  
(n=1,484) 
Prospective and 
Retrospective 
design 
To identify and evaluate 
current OSA screening 
questionnaires  
Review consisted of 10 studies used to 
calculate pooled sensitivity and 
specificity of OSA screening 
questionnaires ability in detecting OSA. 
The Haraldsson questionnaire had 
highest pooled sensitivity in patients 
with a history of a sleep disorder. 
The Stop-Bang questionnaire had the 
highest sensitivity in screening for OSA 
in patients without a history of sleep 
disorders. 
The Berlin questionnaire had the 
highest pooled specificity in screening 
for OSA in patients without a history of 
sleep disorders. 
Considering tools feasibility, accuracy, 
and generalizability the authors 
recommend using either the STOP 
questionnaire or the STOP-Bang 
questionnaire. 
 
 
A 
 
Nagappa, M., Liao, 
P., Wong, J., 
Auckley, D., 
Ramachandran, S., 
Memtsoudis, S., . . . 
Chung, F. (2015). 
Validation of the 
STOP-bang 
questionnaire as a 
screening tool for 
obstructive sleep 
apnea among 
different 
 
Systematic 
Review/ 
Level 5 
 
17 studies 
(n=9,206) 
Prospective and 
retrospective 
design  
 
To validate the accuracy 
of the STOP-Bang 
questionnaire as an OSA 
screening tool in sleep 
clinic and surgical 
patients.  
Meta-analysis performed 
to compare sensitivity and 
specificity 
 
The purpose of the review was to 
evaluate the effectiveness of the 
STOP-Bang screening questionnaires 
diagnostic accuracy in patients 
suspected to have OSA in the sleep 
clinic and surgical populations. 
The SBQ was validated as an excellent 
screening tool in sleep clinic and 
surgical patients. Pooled sensitivity in 
the sleep clinic and surgical population 
were 94% and 91%; specificity was 
34% and 32%. Probability of moderate 
 
A 
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populations: A 
systematic review 
and meta-analysis. 
Plos One, 10(12), 
e0143697. 
doi:10.1371/journal.
pone.0143697 
and severe OSA steadily increased 
with increasing SBQ scores. 
 
 
 
Chiu, H., Chen, P., 
Chuang, L., Chen, 
N., Tu, Y., Hsieh, 
Y., . . . 
Guilleminault, C. 
(2016). Diagnostic 
accuracy of the 
berlin 
questionnaire, 
STOP-BANG, 
STOP, and epworth 
sleepiness scale in 
detecting 
obstructive sleep 
apnea: A bivariate 
meta-
analysis. Sleep 
Medicine 
Reviews, 36, 57-70. 
doi:10.1016/j.smrv.
2016.10.004 
 
 
Systematic 
Review/Meta-
analysis 
Level 5 
 
73 studies 
(n=47,989)  
Varying design 
and quality of 
studies 
 
Purpose was to analyze 
and compare diagnostic 
accuracy of several OSA 
screening tools.  
 
Based on the meta-analysis 
calculations of pooled sensitivities and 
specificities, it was determined that the 
STOP-Bang Questionnaire had the 
highest sensitivity of detecting OSA 
compared to the other tools. The 
pooled sensitivities in detecting severe 
OSA using the SBQ compared to the 
ESS was 93% and 58% respectively. 
However, the ESS had higher 
specificity at 60% compared to the 
SBQ at 35%. The STOP-Bang 
questionnaire was endorsed as the 
superior and recommended tool in 
detecting mild, moderate, and severe 
OSA 
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Bibbins-Domingo, 
K., Grossman, D. 
C., Curry, S. J., 
Davidson, K. W., 
Epling, J. W., 
García, F. A. R., . . . 
US Preventive 
Services Task 
Force. (2017). 
Screening for 
obstructive sleep 
apnea in adults: US 
preventive services 
task force 
recommendation 
statement. Jama, 3
17(4), 407-414. 
doi:10.1001/jama.2
016.20325 
 
Recommend
ation 
statement/  
Level 7  
Studies used not 
clearly specified. 
Referencing 
USPSTF 
systematic 
review  
Issue a recommendation 
statement of screening 
asymptomatic patients for 
OSA 
Supported that there was insufficient 
evidence to provide a recommendation 
of screening for OSA in asymptomatic 
patients. However, was able to provide 
a definition determining which patients 
should be considered 
asymptomatic.  Asymptomatic patients 
were defined as those with 
unrecognized symptoms or those that 
did not report their symptoms as a 
concern to their clinician. These 
excluded patients presenting with 
symptoms of OSA including snoring, 
witnessed apnea, excessive daytime 
sleepiness, impaired cognition, mood 
changes, or gasping or choking at 
night. Furthermore, this 
recommendation excluded children, 
adolescents, pregnant women, patients 
reporting concerns of OSA, those that 
have been referred for suspected OSA, 
and patients that have acute conditions 
that could trigger the onset of OSA 
such as stroke. 
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Aurora, R. N., Quan 
S. F. (2016). Quality 
measure for 
screening for adult 
obstructive sleep 
apnea by primary 
care physicians. 
Journal Clinical 
Sleep Medicine. 12 
(8). P. 1185-1187 
 
Quality 
Measure/ 
Level 7 
 
Studies utilized 
not disclosed 
 
Establish measure for 
primary care providers to 
appropriately screen for 
OSA in effort to reduce 
frequency of undiagnosed 
OSA. 
 
Patients that are considered at high-
risk for OSA should be screened every 
12 months. High-risk patients were 
defined as patients with obesity (BMI  
30kg/m2), congestive heart failure, 
atrial fibrillation, treatment resistant 
hypertension (blood pressure above 
goal despite adherence to 
antihypertensive regimen of 3 
medications, or hypertension controlled 
by at least 4 medications), impaired 
glucose tolerance or type 2 diabetes, 
nocturnal dysrhythmias, stroke, 
pulmonary hypertension, preoperative 
for bariatric surgery, or coronary artery 
disease. Recommended using OSA-
specific screening questionnaires over 
sleepiness scales. 
 
C 
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Appraisal of Relevant Evidence 
Level 1 evidence. The Adult OSA Task Force of the American Academy of Sleep 
Medicine (AASM) performed a review of current literature and practice guidelines to produce a 
clinical guideline for the evaluation, management, and long-term care of OSA in adults (Epstein 
et al., 2009). After appraising the current and relevant evidence, the committee delineated 
practice parameters consisting of standards, guidelines, and opinions based on the strength of 
the available evidence and expert consensus. Topics of practice parameters included 
screening, diagnostic testing, and treatment. 
For the screening of OSA in the primary care setting, the task force produced a 
consensus statement detailing three patient population that should be screened including 
patients presenting for routine health maintenance evaluations, patients reporting symptoms 
suggestive of OSA, and patients that are high-risk for OSA. The recommendation suggested 
that as a part of routine health maintenance evaluations, questions inquiring of patient snoring 
and daytime sleepiness should be included to every patient. Also, patients that reported 
symptoms of witnessed apneas, snoring, gasping or choking at night, excessive sleepiness not 
explained by other factors, non-refreshing sleep, fragmented sleep, morning headaches, 
decreased concentration, memory loss, decreased libido, and irritability should trigger a further 
evaluation and screening. Along with patients reporting positive findings, those with 
retrognathia, hypertension, and obesity were all recommended to receive screening for OSA. 
The third patient population that should prompt additional screening for OSA includes patients 
that are considered at-risk. The guideline defines high risk patients as those that are obese (BMI 
≥35 kg/m2), have congestive heart failure, atrial fibrillation, treatment refractory hypertension, 
type 2 diabetes, stroke, nocturnal dysrhythmias, pulmonary hypertension, high-risk driving 
populations (i.e. commercial truck drivers), and patients undergoing evaluation for bariatric 
surgery.  
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Patients that are considered at-risk for OSA within the three populations are 
recommended to be further evaluated with a comprehensive sleep history and physical 
examination to determine if a sleep study is warranted. A sleep history is suggested to evaluate 
snoring, witnessed apneas, gasping/choking episodes, excessive sleepiness not explained by 
other factors, severity of sleepiness defined by the Epworth Sleepiness Scale, total amount of 
sleep, nocturia, morning headaches, fragmented sleep, insomnia, and decreased concentration 
or memory. Physical examination focusing on risk factors for OSA should include presence of 
obesity, upper airway narrowing, increased neck circumference, retrognathia, lateral peritonsillar 
narrowing, macroglossia, tonsillar hypertrophy, elongated/enlarged uvula, high arched/narrow 
hard palate, and nasal abnormalities such as polyps, deviations, and turbinate hypertrophy. 
Patients with positive sleep history findings or physical exam findings suggestive of OSA are 
then recommended to be referred for a sleep study. Overall, these practice guidelines lend 
value by defining patients that are at-risk for OSA and necessitate screening. However, there is 
limited documentation of the search strategy or discussion on the quality of studies utilized in 
the practice recommendations making this guideline poor quality.  
Level 5 evidence. Jonas et al., (2017) performed an extensive systematic review to 
analyze the current evidence of screening, test accuracy, and treatment of OSA to guide a 
USPSTF recommendation statement. The review consisted mainly of randomized clinical trials 
with some prospective cohort studies. Eight key clinical questions were addressed ranging from 
topics of screening to treating OSA with evidence rationales provided for each to support the 
recommendation.  
The first key question sought to determine if there were any health benefits achieved 
from screening every adult for OSA. However, it was discovered that no eligible studies existed 
comparing health outcomes of universally screening compared to no screening. Due to the 
limited evidence, the review concluded that there was insufficient evidence to determine if 
screening every patient for OSA provided clinical utility. Despite the reviews limited findings, this 
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supported the decision not to universally screen asymptomatic patients as this is not yet 
supported by current evidence. Of note, other key questions addressed the effect of OSA 
treatment on immediate health outcomes. All relevant studies demonstrated a majority of 
patient’s apnea-hypopnea index (AHI) scores returned to less than five which is considered 
normal, in patients treated with CPAP compared to those with placebo CPAP. Additionally, 29 
trials identified a two-three-point reduction of diurnal systolic blood pressure associated with 
CPAP treatment in OSA patients. These findings demonstrate the positive health benefits 
associated with treatment therapies thus highlighting the importance of identifying undiagnosed 
patients to begin treatment. Overall, this systematic review is of high quality. The review 
provided an exceptional documentation of literature search strategy and quality of each study 
utilized for each key question recommendation.   
Miller and Berger (2015) performed a systematic review with a focus on screening and 
assessing for OSA in the primary care setting utilizing 17 studies consisting of experimental 
study designs, descriptive, and mixed methods studies. The integrative review recognized that 
sleep disorders are common yet rarely assessed necessitating further education of primary care 
providers ability in detecting OSA and serves as the basis of this review. 
  The authors discussed patient populations that should be considered appropriate for 
screening. The findings highlighted three appropriate populations that should necessitate 
screening which included any adult patient complaining of symptoms suggestive of OSA, every 
patient during an annual well-visit, and in all patients that are considered high-risk. Signs and 
symptoms triggering further evaluation should include snoring, witnessed apneas, nocturnal 
gasping/choking, unexplained daytime sleepiness, large neck circumference (>17 inches in 
men, >16 inches in women), sleep fragmentation/insomnia, and non-refreshing sleep. Although 
snoring and daytime sleepiness is closely associated with OSA, these predictors lack reliability 
as effective independent predictors. The study also found that screening should take place as a 
part of the review of symptoms during routine health maintenance visits. Sleep health should be 
EFFECTS OF  32 
discussed with each patient providing a time to recognize signs and symptoms prompting 
further evaluation for OSA. The study also found that high-risk patients necessitating screening 
were defined as those with obesity (BMI >35 kg/m2), cardiac or metabolic comorbid conditions 
(congestive heart failure, atrial fibrillation, hypertension, type 2 diabetes, nocturnal cardiac 
dysrhythmias, stroke, and pulmonary hypertension), and patients that are pre-operative for 
bariatric surgery.  
Patients that were classified within these three groups were considered at-risk of OSA 
and were recommended to be screened for OSA. Screening tools were described as a quick 
and cost-effective method in predicting the presence of OSA and indicates the need to refer for 
a confirmative sleep study. The review focuses on analyzing the performance data of the most 
widely tested screening tools including the Berlin Questionnaire, Epworth Sleepiness Scale, 
STOP questionnaire, and the STOP-Bang questionnaire. By comparing the sensitivity and 
specificity of the psychometric tools across the studies, the Berlin Questionnaire and STOP-
Bang questionnaire demonstrated the current best measure in screening for moderate to severe 
OSA. The integrative review offered valuable evidence supporting which patients should be 
screened and the best tools to screen those patients. Overall, the review is of high quality. 
Detailed documentation of the search strategy was provided with inclusion and exclusion criteria 
specified resulting in an identifiable number of studies included. A description of each study was 
included as well as design and quality of evidence. Findings were discussed in context of 
limitations such as flaws present in included studies to offer a balanced recommendation in 
screening for OSA. 
Myers, Mrkobrade and Simel (2013) completed a systematic review to assess the 
accuracy of clinical assessment findings ability to diagnosis OSA. Included in the review were 
42 studies of varying designs and quality. Central to the review was the comparison in the 
accuracy of patient reported symptoms and the clinical sign’s sensitivity and specificity in 
detecting OSA.  
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The reported patient symptoms that were compared included nocturnal choking/gasping, 
morning headache, excessive daytime sleepiness, reported apnea, and snoring. Among these 
symptoms, snoring was determined to have the highest sensitivity (90%) and lowest specificity 
(10%) in detecting moderate to severe OSA with a likelihood ratio (95% CI) for a positive test 
result of 1.1. Given the low specificity, it was determined that snoring should not be the 
exclusive symptom and must be evaluated in context of other patient specific information such 
as obesity. Despite snoring’s high sensitivity, it was determined that nocturnal choking or 
gasping was the most useful individual finding with a positive likelihood ratio 3.3. Clinical signs 
or physical exam findings compared included oropharyngeal volume recorded as Mallampati 
class scores and pharyngeal narrowing. Each of these signs had comparable results with the 
Mallampati scores a sensitivity of 55% and specificity of 65% and pharyngeal narrowing scores 
67% and 53% respectively. Given this information, the authors concluded that “individual 
symptoms and signs have limited utility in determining the likelihood of OSA, and no one sign is 
sufficiently precise to rule in or rule out this condition” (p.739). 
Four clinical prediction tools used to screen for OSA were also compared including the 
STOP-Bang questionnaire, Snoring Severity Scale, Berlin Questionnaire, and the Names-2. 
Although a meta-analysis was not performed, sensitivity, specificity, likelihood ratios, and 
probability values from each study were compared for mild (AHI 5) and moderate OSA (AHI 
15).  For mild OSA, the STOP-Bang questionnaire (SBQ) had the highest sensitivity and 
specificity of 88% and 53% respectively. For moderate OSA the Snoring Severity Scale had the 
highest sensitivity and specificity of 97% and 38% respectively compared to SBQ scores of 93% 
and 35%.  Findings are cautioned that studies were largely composed of patients that were 
sampled in settings highly prevalent of OSA, thus limiting the generalizability of the tool’s clinical 
utility. This review was instrumental in determining whether to use a clinical prediction tool with 
combination findings to screen for OSA rather than using individual patient symptoms or signs. 
Overall this review is rated as good quality. A thorough search strategy and inclusion criteria 
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was discussed, but quality of studies utilized was not addressed limiting the strength of the 
findings.  
Abrishami, Khajehdehi and Chung (2010) performed a systematic review evaluating 
existing OSA screening questionnaires. The review consisted of ten studies (n=1,484) including 
prospective and retrospective designs and calculated pooled sensitivity and specificity. The 
authors discussed that while polysomnography is the accepted gold standard in diagnosing 
OSA, the test is costly and not easily accessible. Therefore, screening tools are valuable in 
ascertaining patients at-risk before a sleep study referral.  
 The screening tools in the comparison were the Berlin Questionnaire, Wisconsin Sleep 
Questionnaire, STOP Questionnaire, STOP-Bang Questionnaire (SBQ), ASA checklist, Sleep 
Apnea scale of the Sleep Disorders Questionnaire, Haraldsson’s, and Apnea Score. The review  
demonstrated that the STOP-Bang questionnaire had the highest pooled sensitivity and the 
Berlin Questionnaire had the highest pooled specificity in predicating moderate to severe OSA. 
The authors produced their final recommendation based on three criteria consisting of 
feasibility, accuracy, and generalizability. The authors determined that both the STOP and SBQ 
had fewer and more straightforward questions lending to increased feasibility. The accuracy of 
the SBQ was demonstrated to have the highest pooled sensitivity in detecting moderate to 
severe OSA as well as the authors judgement that the SBQ was of high methodological quality 
and validity. Generalizability of the screening tools were limited due to a majority of the tools 
being developed using high-risk patients, thus making them best suited for setting such as sleep 
clinics or surgery. Although the authors acknowledge the imperfections and limitations, the 
STOP and SBQ were the recommended screening tools. This review provides an insightful 
evaluation of the strengths and weakness in selecting the SBQ as the preferred screening tool. 
Although the sample of included studies was smaller, the authors provided an extensive search 
strategy documentation and specified inclusion criteria. The method and quality of each study 
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was detailed aiding the credibility of the results. A thorough review of findings in context of 
strengths and limitations allowed for logical recommendations making this review high-quality.  
Nagappa et al. (2015) performed a systematic review and meta-analysis focusing on the 
STOP-Bang questionnaire in screening for OSA. The review was comprised of 17 studies 
(n=9,206) of varying designs and quality. The purpose of the review was to evaluate the 
effectiveness of the STOP-Bang screening questionnaires diagnostic accuracy in patients 
suspected to have OSA in the sleep clinic and surgical populations. 
 Pooled predictive parameters were formulated based on extracted data from each study 
that was included. Results demonstrated a 94% and 91% sensitivity in predicting moderate to 
severe OSA in sleep clinic and surgical patients respectively. Specificity was 34% in sleep clinic 
studies and 32% in surgical population studies. Inferences from the results demonstrated a 
direct positive relationship between STOP-Bang questionnaire scores and the presence of OSA. 
In other words, the higher the STOP-Bang score correlated with increased probability of an OSA 
diagnosis. To ensure consistency all included studies confirmed a diagnosis with a method of 
polysomnography. Using the analysis results, the authors concluded that the STOP-Bang 
questionnaire consistently demonstrated high sensitivity in detecting OSA in suspected patients 
and is recommended as a useful screening tool in high-risk patients. This review provided 
affirmation that the STOP-Bang questionnaire was an accurate tool for screening in high-risk 
patients. Although the review focused on patients in the sleep clinic and surgical population, 
these represent high-risk patient populations which is consistent with the project’s target 
participants. Detailed search strategy documentation was provided as well as identifiable 
inclusion and exclusion criteria. The authors acknowledged limitations of the study including 
possible oversampling of high-risk patients threatening the findings generalizability. This was 
due to the study’s’ sample being obtained from sleep clinics and surgical patients which might 
not accurately represent the general population. However, logical conclusions were drawn using 
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the meta-analysis results that the SBQ offered an effective method providing an accurate quick 
screening for OSA across different settings and is a high-quality review.     
Chiu et al. (2017) published a systematic review and meta-analysis analyzing the 
diagnostic accuracy of several OSA screening tools. The analysis was composed of 73 studies 
of differing designs with a combined sample size of 47,989 participants. The review was initiated 
after identifying the estimated high occurrence of undiagnosed patients and the substantial 
burden of the medical condition left untreated.  
 The clinical screening tools that were assessed and compared included the Berlin 
Questionnaire, STOP-Bang Questionnaire, STOP questionnaire, and Epworth Sleepiness 
Scale. Bivariate statistical analysis was performed with results including pooled sensitivity and 
specificity.  Based on the meta-analysis calculations of pooled sensitivities and specificities, it 
was determined that the STOP-Bang Questionnaire had the highest sensitivity of detecting OSA 
compared to the other tools. The pooled sensitivities in detecting severe OSA using the SBQ 
compared to the ESS was 93% and 58% respectively. However, the ESS had higher specificity 
at 60% compared to the SBQ at 35%. A determination was made that a higher sensitivity had 
more value in clinical practice with the increased capability of early detection with more accurate 
findings. Therefore, given the superior sensitivity and overall feasibility, the STOP-Bang 
questionnaire was endorsed as the superior and recommended tool in detecting mild, moderate, 
and severe OSA. This review was instrumental in determining which screening tool was 
superior and preferred. The review demonstrated a methodological and exhaustive search 
strategy producing a robust sample size. Limitations were addressed including use of varying 
levels of methodological rigor among the studies. Studies were completed in different clinical 
settings which limited the ability to generalize results. Recommendations were provided with 
logical rationales and support from the evidence. Overall, the review is of high quality. 
Level 7 evidence. Bibbins-Domingo et al. (2017) published a recommendation 
statement for the USPSTF primarily based on results from Jonas et al. (2017) systematic review 
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findings. The statement sought to provide a recommendation on screening for OSA in 
asymptomatic patients.  
As previously discussed, this USPSTF review determined that there was insufficient 
evidence in assessing the benefits or utility of screening asymptomatic patients. Using these 
findings, the recommendation statement determined that they were unable to provide a 
recommendation supporting or advising against screening asymptomatic patients. Despite the 
inconclusive recommendation statement, the review was imperative by offering defining criteria 
to distinguish asymptomatic and high-risk patients. Asymptomatic patients were defined as 
those with unrecognized symptoms or those that did not report their symptoms as a concern to 
their clinician. These excluded patients presenting with symptoms of OSA including snoring, 
witnessed apnea, excessive daytime sleepiness, impaired cognition, mood changes, or gasping 
or choking at night. Furthermore, this recommendation excluded children, adolescents, pregnant 
women, patients reporting concerns of OSA, those that have been referred for suspected OSA, 
and patients that have acute conditions that could trigger the onset of OSA such as stroke. By 
establishing defined screening criteria, this ensures that this recommendation statement is 
applied to appropriate patients and those that warrant screening are not missed due to 
ambiguous guidelines. This review statement was influential in ensuring that the patient 
population being screened was based on current evidence. With no identifiable evidence 
supporting screening every patient, this serves as a foundation for screening at-risk populations. 
Overall, the recommendation statement is of good quality based on thoroughness and 
evaluation of recommendations provided.  However, the recommendation did not make clear 
the evidence that was being utilized as the basis of the statement. Also, in defining the patient 
population the research was vague on which acute conditions are excluded in the 
recommendation aside from stroke. This is important as without clear delineation of acute 
conditions that should trigger screening, patient populations can be inappropriately missed and 
left undiagnosed.   
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Aurora and Quan (2016) describe a quality measure assisted by American Academy of 
Sleep Medicine staff and Workgroup members. The guideline was developed after a review of 
the literature limited to guidelines, meta-analyses, and systematic reviews. There were 364 
studies retrieved with an unidentifiable number utilized in the final measure. The aim of the 
measure was to offer a recommendation of screening for OSA in the primary care setting in an 
effort to reduce the frequency of undiagnosed OSA.  
One facet of OSA that was addressed was which patients should be screened. Rather 
than screening being universal to every patient, it was determined that screening should be 
limited to high-risk populations every 12 months. High-risk patients were defined as patients 
with obesity (BMI 30kg/m2), congestive heart failure, atrial fibrillation, treatment resistant 
hypertension (blood pressure above goal despite adherence to antihypertensive regimen of 3 
medications, or hypertension controlled by at least 4 medications), impaired glucose tolerance 
or type 2 diabetes, nocturnal dysrhythmias, stroke, pulmonary hypertension, preoperative for 
bariatric surgery, or coronary artery disease. Due to the high prevalence of OSA in these 
conditions, early identification and treatment of OSA can potentially improve health outcomes 
associated with certain conditions. Next, the authors briefly discuss recommended screening 
tools as a means of early identification prompting diagnostic testing. While a specified screening 
tool was not endorsed, the recommendation asserts that a validated OSA-specific questionnaire 
is available and preferred. Additionally, it was recommended that sleepiness scales are to be 
avoided as they screen for sleepiness from any cause, thus not specific to OSA. Concepts from 
this quality measure were valuable in reinforcing the appropriate patient populations to screen 
for OSA along with the ideal methods of screening. Due to the limited discussion of studies 
included and their quality, this measure is of poor quality.  
Construct EBP 
Synthesis of literature. The best practice model of screening for obstructive sleep 
apnea (OSA) in the family practice setting is a protocol comprised of two concepts. Upon 
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critically appraising and synthesizing the current best-evidence, recommendations included (a) 
screening for OSA in patients that are considered at-risk, and (b) utilization of the STOP-Bang 
questionnaire to increase providers’ adherence of effectively screening for OSA.   
Screening in at-risk patients. Across the literature there is consensus that not every 
patient in the family practice setting should be screened for OSA. Bibbins-Domingo et al. (2017) 
determined that there is currently insufficient evidence to suggest screening for OSA in 
asymptomatic patients. Furthermore, the available screening tools were not designed to detect 
OSA in the general patient population, rendering them ineffective to screen asymptomatic 
patients (Bibbins-Domingo et al., 2017). However, evidence has shown that there is value in 
screening for OSA in patients that are considered at-risk. Undiagnosed and untreated patients 
have a higher association of type 2 diabetes, hypertension, and stroke which are leading causes 
of morbidity and mortality establishing credence of screening (American Sleep Apnea 
Association [ASAA], 2017). At-risk populations have been defined as patients with obesity (BMI 
≥35kg/m2),congestive heart failure, atrial fibrillation, treatment resistant hypertension (blood 
pressure above goal despite adherence to antihypertensive regimen of 3 medications or 
hypertension controlled by at least 4 medications), impaired glucose tolerance or type 2 
diabetes, nocturnal dysrhythmias, stroke, pulmonary hypertension, preoperative for bariatric 
surgery, and coronary artery disease (Aurora & Quan, 2016; Epstein et al., 2009). Given the 
higher occurrence of OSA among these patient populations, the patients are considered at-risk 
and should be screened annually. 
STOP-Bang Screening Questionnaire. After reviewing and appraising the literature 
evaluating the recommended method for screening at-risk patients for OSA, the STOP-Bang 
questionnaire (SBQ) was selected as the optimal tool. While no screening tool is diagnostic, the 
SBQ has consistently demonstrated superior sensitivity in accurately detecting OSA in at-risk 
patients (Kline, 2018, Abrishami, Khajehdehi & Chung, 2010; Nagappa et al., Chiu et al., 2016). 
While some studies demonstrated comparable sensitivities of the SBQ and other screening 
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tools, the SBQ had more consistent results across numerous studies (Miller & Berger, 2015; 
Kline, 2018; Abrishami, Khajehdehi & Chung, 2010; Nagappa et al.; Chiu et al., 2016).The SBQ 
was designed with the intent of detecting OSA in at-risk patients which is preferred over 
sleepiness scales that aren’t designed specifically for OSA (Aurora & Quan, 2016). SBQ scores 
of five or greater indicate high-risk of OSA and should then be referred for diagnostic testing 
(Kline, 2018).  
Clinical Question 
 The goal of this EBP project was to enhance providers adherence to screening for OSA 
in the primary care setting with the use of a developed protocol using current best-evidence. 
The PICOT question developed was “In the internal medicine setting, how does implementation 
of a revised obstructive sleep apnea screening protocol affect providers’ adherence to screening 
over a one-month period as compared to current practice?”. 
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CHAPTER 3 
IMPLEMENTATION OF PRACTICE CHANGE 
Implementation of this evidence-based practice (EBP) project was performed over 
several months and encompassed the utilization of the John Hopkins Nursing Evidence-Based 
Practice model as a guide. The primary goal during the implementation period was to improve 
providers’ adherence of screening for obstructive sleep apnea (OSA) in adults as supported by 
current best-practice evidence in the family practice setting. Providers’ adherence to protocol 
recommendations was measured by comparing adherence six weeks prior to protocol 
introduction to the six weeks after implementation. The steps of the John Hopkins Nursing 
Evidence-Based Practice model served as a guide to promote the successful translation of best 
evidence into practice. 
Setting and Participants 
The setting for the EBP project implementation was located at a privately-owned family 
medicine practice located in northwest Indiana. The practice provides medical services to all 
ages, with a majority of the patients over the age of 18 years old. Office staff consists of a 
physician, nurse practitioner, registered nurse, nutritionist, medical assistants, front-desk 
secretaries, and an office manager. Each provider sees an average of 20 patients per day. As 
the primary outcome of this project aimed to measure providers’ adherence to a best practice 
OSA screening protocol, the physician and nurse practitioner were the target participants. 
Permission for project implementation was granted from the physician/owner of the practice as 
well as the nurse practitioner onsite following discussions and explanation of the current best 
evidence regarding screening for OSA. 
As the project entailed implementing a protocol to increase providers adherence to 
screening (see appendix A), the effect was determined by comparing adherence between a pre- 
and post-intervention group.  The pre-intervention group was comprised of patients that were 
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identified as at-risk and whether or not OSA screening was performed during 6 weeks prior to 
project implementation (Summer 2018). To gather this data, every patients’ electronic medical 
record was audited during the specified timeframe. Data was manually extracted from the charts 
which included recording every patient considered at-risk and if screening was performed (see 
Appendix C). If screening was performed, the score from the screening questionnaire was then 
recorded and whether or not that patient was referred for a polysomnography. Data for the post-
intervention group was collected in the same fashion by completing a records log of data 
obtained through manual chart audits of patients during the specified implementation time 
period. To determine the effect of the providers’ adherence to the protocol, the pre-intervention 
group served as a baseline and was compared to the adherence of the post-intervention group.  
Outcomes 
The primary outcome examined for this EBP project was the measurement of providers’ 
adherence to the utilization of the developed OSA screening protocol. The screening protocol 
consisted of two components which advised (a) identifying at-risk patients and (b) utilization of 
the STOP-Bang questionnaire in screening those patients identified as at-risk for OSA. Provider 
adherence was satisfied when both protocol criteria were fulfilled including screening patients 
with an at-risk diagnosis by using the STOP-Bang questionnaire. For example, if the provider 
screened a patient with a history of atrial fibrillation for OSA by using the STOP-Bang 
questionnaire this represented adherence to the protocol being that the provider screened a 
patient with an at-risk diagnosis using the recommended screening method. Adherence to the 
protocol components was evaluated for every at-risk patient visit during the implementation 
phase and was compared to the pre-intervention group.  
Secondary outcomes that were examined measured the incidence of providers’ referral 
for diagnostic testing as a result of the screening protocol. For patients that were screened for 
OSA, their charts were then further reviewed to evaluate if the provider ordered additional 
diagnostic testing such as home sleep apnea testing or polysomnography. Last, for patients 
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which OSA diagnostic testing was ordered, charts were further reviewed to record the 
occurrence of a confirmed OSA diagnosis.  
Intervention 
A systematic search across multiple databases was performed to gather current 
evidence supporting the intervention. All relevant evidence was appraised and synthesized to 
ensure best practice recommendations were obtained and utilized in developing the protocol. 
The project’s proposed protocol served to replace the practice’s current guidelines of screening 
for OSA. Prior to project implementation, the practice had a vague and rarely referenced OSA 
screening guideline. The guideline failed to specify which patients should be screened, but it 
was stated that the STOP-Bang questionnaire was the approved screening method. Despite the 
guideline recommendations, the document was rarely referenced, and medical staff reported 
using a different screening tool with patients. The protocol was designed in an easy-to-read 
standard format to help providers determine which patients the literature recommended to be 
screened and the best method to screen those identified as at-risk. The developed protocol 
included the addition of current best-evidence recommendations that included screening 
specified patients that were considered at-risk for OSA and supported the use of the STOP-
Bang questionnaire.  
Project implementation commenced by meeting with each provider individually in mid-
October 2018 with a discussion regarding the plan for the implementation of the protocol in 
effort to promote a smooth transition period. The project coordinator supplied the providers and 
staff members with educational handouts related to the importance of identifying and treating 
OSA. The project coordinator was in contact with providers weekly to communicate identified 
patients that should be screened based on protocol guidelines and was available for questions. 
Results were reviewed with providers half-way through the implementation phase and at the 
end for continuity. The duration of the project was 6 weeks and implementation concluded at the 
end of November 2018.  
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Planning 
Planning for the project was initiated by arranging a meeting with both of the project site 
providers in the summer of 2018. After explaining the prevalence and impact of undiagnosed 
OSA, the project was proposed, and interest was mutually expressed to develop an enhanced 
method of screening for OSA.  
The protocol was designed following a thorough search and evaluation of the literature. 
By evaluating the current best-evidence related to screening for OSA, it was determined that the 
current screening policy did not reflect best-practice and supported the development of a new 
screening protocol. The new protocol developed was comprised of two main components that 
specified at-risk patients that should be screened and supported utilization of the STOP-Bang 
questionnaire in screening those patients identified as at-risk (see Appendix A). 
The John Hopkins Nursing Evidence-Based Practice served as a guide for the project, 
with corresponding steps within the model being utilized during the planning and implementation 
stage.  As recommended by Step 11 of the model which suggests evaluating if the change is an 
appropriate match to the setting and timing. Accordingly, prior to project implementation the 
proposed protocol was presented to the project site providers to review for appropriateness and 
feasibility. Step 12 which states to create an action, was essential in facilitating project 
implementation and included the development of an action plan by the project coordinator. 
Aspects of the action plan included a timeline for obtaining baseline data, and preparation of 
staff for implementation and evaluation. Securing support and resources needed for project 
implementation as directed by Step 13 was beneficial in promoting project adherence by the 
staff members. Copies of the protocol were supplied to all staff members two weeks before 
project implementation to increase the staff’s familiarity to the components of the protocol in an 
effort to promote adherence. Resources needed for the project were secured by printing copies 
of the protocol and screening questionnaires to supply the duration of the project.  
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Recruiting Participants 
The primary aim of the project was to increase providers’ adherence to screening for 
OSA. The participants consisted of the two providers at the practice, which included the 
physician and nurse practitioner. Performing individualized non-invasive screenings are within 
the scope of practice for every family practice provider to promote optimal patient outcomes. 
Given the purpose of the study corresponded with the roles and scope of practice of the 
providers they were the target participants recruited for project implementation.  
Data 
Measures and their reliability and validity. Data for the project were collected 
manually by the project coordinator using a self-developed data collection sheet and completed 
STOP-Bang questionnaire forms. External validity may be compromised due to the Hawthorne 
effect. The Hawthorne effect describes a phenomenon when subjects behaviors are influenced 
by participating in a study resulting in changes to the dependent variable rather than the 
changes being attributed to the intervention (Peters, 2015). In this project, providers’ awareness 
that their compliance was being analyzed post-intervention represents a potential threat to 
validity.  
Collection. Data collection began in June 2018 and was completed in October 2018 
prior to the project initiation. Project implementation ran from October 2018 through the end of 
November 2018. Data collected reflected providers’ adherence to the protocol including (a) 
identifying patients at-risk for OSA and (b) utilizing the STOP-Bang questionnaire to screen 
patients that were identified as at-risk. In order for the provider to be considered adherent to the 
protocol, both components needed to be fulfilled.  
Providers’ adherence to screening the correct patients outlined by the protocol was 
measured during weekly audits of patient’s electronic medical records by the project 
coordinator. During the implementation phase, patients with established appointments had a 
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chart review completed weekly to determine if screening for OSA was indicated. Criteria that 
determined which patients necessitated screening was detailed in the protocol and accessible to 
each provider. Through manual chart audits, the project coordinator determined which patients 
met the criteria for screening and if screening was indeed performed by the provider or omitted. 
The data was organized in a self-constructed log that listed each patient that should have been 
screened, if OSA screening was performed, and if referral for diagnostic testing was ordered. 
Additional demographic information was also obtained including the age, gender, and significant 
medical history placing the patient at-risk for OSA. 
Providers’ adherence to using the STOP-Bang questionnaire was examined by 
quantifying the number of completed screening questionnaires of at-risk patients through a 
weekly chart audit. During weekly chart audits, the project coordinator identified patients that the 
providers should screen for OSA based on criteria detailed in the protocol. Completed STOP-
Bang questionnaires were gathered each week with the date and patients confidential code. If 
there was a completed STOP-Bang questionnaire obtained for a patient that was identified as 
at-risk, it was determined that the providers were adherent to the protocol. Likewise, if a STOP-
Bang questionnaire was not completed or if another screening tool was used by the provider for 
a patient identified as at-risk it was determined that the provider was non-adherent.  
Management and Analysis. All data management and analysis were performed by the 
project coordinator with the primary objective of comparing providers’ adherence of screening 
for OSA prior to the introduction of the protocol to the adherence post-intervention. Data that 
was collected represented nominal level data. Provider adherence was then compared using a 
chi-square test of independence to determine if any differences existed between the pre- and 
post-intervention groups. Statistical calculations were performed using SPSS software. 
Protection of Human Subjects 
Before project implementation, approval was granted from the Valparaiso University 
Institutional Review Board (IRB). Additionally, project approval was verified in writing by clinical 
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site facilitators. Patients were informed by the providers that screening could be refused to 
maintain patient autonomy and consent. Patient confidentiality was priority and included 
safeguards such as keeping all data in a locked drawer. After patient completion of the STOP-
Bang questionnaire scores were logged and identifiable information was erased using a 
permanent marker.  
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CHAPTER 4 
FINDINGS 
This EBP project was developed to provide an evidence-based approach that aimed to 
improve providers’ adherence to screening for obstructive sleep apnea (OSA) in the primary 
care setting. The PICOT question posed for this project was: “In the internal medicine setting, 
how does implementation of a revised obstructive sleep apnea screening protocol affect 
providers’ adherence to screening over a one-month period as compared to current practice?”. 
To evaluate and determine the effectiveness of the screening protocol, providers’ adherence to 
screening were recorded before and after implementation and compared for statistical 
differences. Secondary outcomes that were analyzed assessed the effect of the project on the 
incidence of providers’ referral for diagnostic testing for OSA and the incidence of subjects 
newly diagnosed with OSA. The following data analysis evaluates the impact of the project by 
comparing providers’ adherence pre intervention to their adherence post intervention.  
Sample 
 Pre intervention group characteristics. The pre intervention group was composed of 
144 audits of electronic medical records. The charts comprising the sample included adults 
aged 18 years and older with an established at-risk diagnosis for OSA who had presented to the 
project-site clinic between July 9, 2018 and August 6, 2018. Of the pre intervention group, 64 
(44.4%) were male and 80 (55.6%) were female. The age range most frequently encountered 
with an at-risk diagnosis was 60-69 (25.7%) years old. The most frequently occurring at-risk 
diagnosis in the pre intervention group was obesity 48 (33.3%) with diabetes mellitus 37 
(25.7%) second (See table 4.1).   
 Post intervention group characteristics. One hundred and twenty-six audited medical 
records comprised the post intervention sample. The sample consisted of at-risk subjects aged 
18 years and older with a scheduled appointment at the project-site between October 23, 2018 
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to November 26, 2018. In the post intervention group there were 67 (53.2%) males and 59 
(46.8%) females. The most frequent age range of at-risk subjects were 50-59 (28.8%) years old. 
The most frequently occurring at-risk diagnosis among the post intervention subjects was 
obesity 44 (35.2%) with diabetes mellitus 25 (20.0%) second (See table 4.1).  
Group comparison. Chi-square test of independence were analyzed comparing the 
participants characteristics including frequency of age (X2(5)=0.585, p>.05), gender (X2(1)= 
2.050, p>.05), and at-risk diagnosis (X2(30)= 26.171, p>.05) between the pre and post 
intervention groups. There were no significant differences between the groups on these 
demographic characteristics (See table 4.1).  
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Table 4.1 
 
Characteristics of the Participants  
 
          Pre Intervention       Post Intervention          Total                X2          df     p value 
                          n (%)                         n (%)                       N (%)               
___________________________________________________________________________________                                    
Total # participants         144                        126 
        
Age Range                                    5.585       5       .349 
  18-29 years  6 (4.2)      6 (4.8)          12 (4.4)   
   30-39 years  29 (20.1)    17 (13.5)          46 (17.0) 
   40-49 years  20 (13.9)    27 (21.4)          47 (17.4) 
   50-59 years  35 (24.3)    37 (29.4)          72 (26.7) 
   60-69 years  37 (25.7)    28 (22.2)          65 (24.1) 
   70+ years   17 (11.8)    11 (8.7)          28 (10.4) 
Gender          2.050        1      .152 
 
    Male               64 (44.4)             67 (53.2)          131 (48.5) 
 
    Female              80 (55.6)             59 (46.8)          139 (51.5) 
 
At-Risk Diagnosis         26.171      30     .666 
 
  Obesity     48 (33.3)              45 (35.7)                  93 (34.4)  
 
  Diabetes  37 (25.7)    25 (19.8)           62 (23.0) 
 
  Obesity and Diabetes 21 (14.6)     20 (15.9)           41 (15.2) 
 
  Uncontrolled   4 (2.8)      5 (4.0)            9 (3.3) 
  Hypertension 
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Changes in Outcomes 
 Statistical testing. Data analysis was performed using IBM SPSS Statistics software, 
version 25.0. To evaluate the primary outcomes chi-square test of independence was performed 
to test the dichotomous variables that examined if at-risk subjects were screened and if the 
STOP-Bang questionnaire was utilized in screening as a reflection of providers’ adherence. 
Secondary outcomes comparing incidence of providers’ referral of subjects for diagnostic testing 
and incidence of participants with a new OSA diagnosis was also evaluated using chi-square 
test of independence.  
 Significance. To answer the PICOT question multiple outcomes were measured in an 
attempt to evaluate the effect of the protocol on providers’ adherence. The components of the 
protocol included first instructing providers’ which subjects are considered at-risk for OSA and 
second directed the use of STOP-Bang Questionnaire for screening at-risk subjects. Providers’ 
adherence to these variables were compared pre and post project implementation to evaluate 
effect.  
Providers’ adherence to screening at-risk subjects were recorded for both pre and post 
intervention groups. In the pre intervention group, providers screened 1 (0.7%) at-risk subject 
compared to 44 (34.9%) at-risk subjects in the post-intervention group (see Figure 4.1). A chi-
square test of independence was calculated comparing providers’ adherence to screening at-
risk subjects for OSA between the two groups and a significant difference was demonstrated 
(X2(1)= 56.679, p<.001). Results are displayed in Table 4.2.  
Providers’ adherence to using the STOP-Bang Questionnaire (SBQ) for screening at-risk 
subjects was recorded and compared between the pre and post intervention groups. In the pre 
intervention group, 0 (0%) subjects were screened using the SBQ compared to 44 (34.9%) 
subjects post intervention (see Figure 4.2). A chi-square test of independence was performed 
comparing providers’ adherence to using the SBQ in screening for OSA in at-risk subjects 
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between the two groups and a significant difference was identified (X2(2)= 60.607, p<.001) as 
shown in Table 4.2. 
Secondary Outcomes 
Secondary outcomes that were analyzed included the effect of the protocol on the 
incidence of providers’ referral of diagnostic testing for OSA and the corresponding incidence of 
subjects with newly confirmed diagnoses of OSA. To determine if a relationship existed between 
the project protocol and number of diagnostic testing referrals completed by the providers, a chi-
square test of independence was performed. Data demonstrated no significant relationship 
between the protocol and providers incidence of referring subjects for OSA diagnostic testing 
(X2(1)= 0.488, p=.485).  
To evaluate if there was an association between the project protocol and number of 
subjects newly diagnosed with OSA, a chi-square test of independence was performed 
comparing the incidence of subjects with a new diagnosis for OSA pre and post intervention. 
Data demonstrated no significant relationship between the protocol and number of subjects with 
a new diagnosis of OSA (X2(1)= 2.810, p=.245). Results are displayed in Table 4.3.  
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Figure 4.1  
Providers’ Adherence to Screening At-Risk Patients  
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Figure 4.2  
Providers’ Adherence to STOP-Bang Questionnaire  
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Table 4.2 
 
Comparison of Providers’ Adherence  
 
                    Pre Intervention            Post Intervention        𝑋2                    df          p value 
                                     n (%)                                n (%)                        
___________________________________________________________________________________                                    
 
At-Risk Patients Screened                             56.679            1             0.001* 
  Yes          1 (0.7)             44 (34.9) 
  No        143 (99.3)                         82 (65.1) 
STOP-Questionnaire 
Used                  60.607            2 0.001* 
 
    Yes                        0 (0)             44 (34.9)           
 
    No            1 (0.7)   0 (0) 
 
* p < .05  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EFFECTS OF  56 
Table 4.3 
 
Secondary Outcomes 
 
                    Pre Intervention            Post Intervention        𝑋2                    df          p value 
                                     n (%)                                n (%)                        
___________________________________________________________________________________                                    
 
Patients Referred          1 (0.7)                       2 (1.6)           .488           1             .485 
Diagnosed OSA          1 (0.7)           2 (1.6)            2.810           1             .245 
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CHAPTER 5 
DISCUSSION 
The purpose of this EBP project was to determine if the implementation of an obstructive 
sleep apnea (OSA) screening protocol in the family practice setting increased providers’ 
adherence to screening for OSA compared to the clinics established method. Secondary 
outcomes that were examined included recording the incidence of diagnostic testing ordered by 
the provider and the confirmed incidence of a new OSA diagnosis as a result of providers’ 
increased adherence to screening by utilizing the protocol.  
Explanation of Findings 
 Primary outcomes. The pre intervention group had 1 at-risk patient that was screened 
for OSA as compared to the post intervention group that had 44 at-risk patients screened. 
Additionally, of the patients screened for OSA in the pre intervention group, 0 were screened 
using the STOP-Bang Questionnaire compared to the 44 patients that were screened using the 
STOP-Bang Questionnaire in the post intervention group. A chi-square test of independence 
comparing the providers’ adherence to screening at-risk patients and the use of the STOP-Bang 
Questionnaire demonstrated a significant difference between the two groups. The 
implementation of the best-practice screening protocol resulted in a significant increase in 
providers’ adherence to screening patients for OSA compared to the previous method.  
 Secondary outcomes. In the pre intervention group, 1 at-risk patient was referred for 
diagnostic testing compared to the post intervention group that had 2 at-risk patients that were 
referred. Furthermore, in the pre intervention group, 1 patient had a confirmed diagnosis of OSA 
while in the post intervention group 2 patients were newly diagnosed. A chi-square test of 
independence determined that there were no significant associations demonstrated when 
comparing the incidence of referral or incidence of participants newly diagnosed with OSA 
between the pre and post intervention group.  
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 The PICOT question for this EBP project, “In the internal medicine setting, how does 
implementation of a revised obstructive sleep apnea screening protocol affect providers’ 
adherence to screening over a one-month period as compared to current practice?” was 
answered by the project results demonstrating a significant increase in providers’ adherence in 
screening at-risk patients using the STOP-Bang questionnaire. Although providers’ adherence 
to screening for OSA was increased, the frequency of patients referred for diagnostic testing 
resulting in an increased number of patients with a clinical diagnosis of OSA did not reflect a 
significant increase.  
Evaluation of the Project: Theory of Planned Change 
 The theory of planned change was used as a guide to promote successful adoption of 
the projects protocol. Central to this theory is the concept that change occurs across three 
stages (a) unfreezing, (b) moving, and (c) refreezing. The theory hypothesizes that a successful 
change is promoted by driving forces outweighing restraining forces that hinder adoption of the 
change.  
 In an effort to promote providers’ adherence to the screening protocol, the three stages 
of change outlined by the theory were utilized as a guide throughout each step of the project. 
The theory facilitated identification of key driving forces that promoted providers’ adherence to 
the implemented protocol. For example, the providers’ expressed desire to uphold best-practice 
standards highlighted within the protocol. This desire, or driving force, was effective as evidence 
by the significant increase in providers’ adherence to utilizing the screening protocol. 
Additionally, as identification of driving forces was instrumental in the effectiveness of providers’ 
willingness to change, the identification of restraining forces was just as important. One 
pervasive restraining force observed during the course of the project was the perception that 
OSA was not a clinical diagnosis demanding foremost attention. Providers would occasionally 
remark that adherence was poor because they had limited time spent with patients that was 
reserved to discussing chronic conditions of greater importance. These observations correlate 
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with findings demonstrating no significant increase in the number of patients referred for 
diagnostic testing. The theory was instrumental during the planning phase of the project by 
identifying factors that either promote or prevent a successful adoption of change but offered 
little guidance during the implementation and evaluation stages.  
Evaluation of the Project: Johns Hopkins Nursing Evidence-Based Practice Model 
 The Johns Hopkins Nursing Evidence-Based Practice Model (JHNEBP) was developed 
with the goal to foster the translation of evidence into each setting of nursing practice (Melnyk & 
Fineout-Overholt, 2015). As the model aims to promote the use of new best-evidence into 
current practice, the application of this model was apparent throughout the entire process of this 
EBP project. Implementation of this model is performed using the PET process which entails the 
three phases of (a) practice question, (b) evidence, and (c) translation. Within each of the three 
phases are multiple prescriptive steps serving to propel the process of evidence translation. 
 The first phase of the JHNEBP model created the foundation of the EBP project by 
developing the practice question. An interest in identifying and managing OSA served as the 
motivation and purpose of this project in the beginning. As detailed by the JHNEBP model, 
during this first phase a PICOT question is developed and refined based on the evidence 
yielded by the literature search. For example, the project PICOT question evolved over time 
based on current recommendations discovered by a thorough search of the literature. The 
original PICOT question sought to determine the effect of screening every patient for OSA and 
comparing the number of patients diagnosed before and after implementation. However, by 
analyzing the evidence it was clear that universal screening is not supported by research thus 
highlighting the need to modify the original PICOT questions. Ultimately the PICOT question 
was later refined to reflect best-evidence and promote a sustainable project. Once the final 
practice PICOT question was determined, key stakeholders were identified, and responsibilities 
were delegated.  
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 After the practice question and implementation schedule was arranged, the project 
entered the second phase of searching the evidence. Aspects of this phase included conducting 
a search of the evidence, appraising the level and quality of each piece of evidence, 
summarizing, synthesizing the strength and quality, and developing recommendations based of 
the synthesis for each piece of evidence (Melnyk & Fineout-Overholt, 2015). Inclusion criteria 
and keywords were diligently reviewed and critiqued with the library liaison ensuring a 
methodological search strategy. Once articles of evidence were selected each were appraised 
for level and quality and then summarized. Concepts from each piece of evidence was 
synthesized and used in the development of the EBP protocol. As recommended by the 
JHNEBP model, a literature search yielding good and consistent evidence supports the initiation 
of a pilot project which propelled this project into the translation phase.  
 The third phase of the JHNEBP model provided a strategic outline to translate the 
evidence obtained into current practice. Following the steps within the phase, feasibility and fit 
were discussed with the project site coordinators. Once an agreement was reached an action 
plan was constructed and necessary resources such as copies of the screening tool and 
measuring tapes were secured. As outlined by the model, outcomes were evaluated and shared 
with stakeholders. Also, next steps and recommendations based on the outcomes were 
identified.  
 The JHNEBP model was effective in providing a general overview of the necessary 
steps of implementing evidence into practice. A strength of the model included dedicating time 
in developing a practice question that is rooted in the literature. The model is nonlinear, which 
allows previous steps to be revisited which was especially useful in refining the practice 
question based on findings from the evidence. Another strength was the explicit guidance of the 
evidence phase which directed the steps of the literature review and provide recommendations 
based on the strength of the evidence. A disadvantage of the model is that the emphasis was 
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on the development of the project offering limited guidance to promote a successful 
implementation.  
Strengths of the EBP Project 
 Strengths of the project included the significant increase of at-risk patients that were 
screened for OSA using the STOP-Bang questionnaire. Although this didn’t correlate with an 
increased number of patients referred for testing or new cases of OSA, it facilitated providers’ 
communication with patients regarding their sleep health during the screening. Another strength 
included the large sample size available to the providers’ to potentially screen. By having a large 
sample size this allowed for greater certainty that the results are associated with the intervention 
rather than a difference between the sample. Since the criteria defining an at-risk patient was 
broad there was a large base of patients that met the protocol inclusion criteria and the ability to 
detect a significant difference of providers’ adherence to screening between the groups. The 
implementation of the project was completed at no direct cost to the clinic site.  
Weaknesses of the EBP Project  
 One of the main weakness of this project was the lack of quality evidence. No studies 
were identified that directly examined the effect of a screening protocol in the family practice 
setting on providers frequency of screening or effect on diagnosing OSA. Inferences had to 
made by extracted concepts from a broad base of evidence to develop a screening protocol that 
reflected the best available evidence.  
 Another important weakness of the project design was not incorporating the effect of 
providers’ beliefs and knowledge of OSA in relation to their adherence to screening. Reflecting 
on the project implementation, it became apparent that just as important as the providers’ not 
being aware of best-practice screening guidelines, was their belief that OSA was not a clinically 
important diagnosis. The implications of the results would have been strengthened if providers 
beliefs and knowledge of OSA would have been measured both before and after 
implementation. Correlations examining if providers’ adherence to screening for OSA was 
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affected by changes in providers’ beliefs and knowledge of OSA may have provided more utility 
and insight. Another potential weakness of the project was the short implementation period. A 
longer pre and post implementation observation would provide more accurate adherence rates 
and inferences of overall sustainability of the project.  
 An additional weakness of the project was the structure of the project site. A frequently 
reported comment made by the providers’ at the site was the issue of being short-staffed of 
medical assistants. During the course of the project, one medical assistant was terminated, and 
two new assistants were hired and were in the process of training. The providers’ reported that 
as a result of the staffing issues they were having to assume more of the workload leaving less 
time to dedicate to adhering to the project.  
Implications for the Future 
 Practice. Practice recommendations garnered from this EBP project outcomes are 
indifferent and don’t provide straightforward clinical recommendations. Despite the significant 
increase of providers’ adherence to screening, the clinical significance must be evaluated since 
the increase in screening didn’t positively correlate with an increased diagnosis of OSA. In order 
for any screening protocol to be effective, its use must be justified by leading to a greater 
number of OSA diagnosis detected making it clinically significant.  However, concepts from the 
policy are easily sustainable and can be readily referenced in the future during screening. 
Results from this practice site can be easily applied and generalized to other family practice 
settings.  
 To enhance sustainability at the project site a more streamlined process is 
recommended for greater adherence and clinical significance. Since providers’ expressed a 
desire to be amenable to the protocol but experienced staffing issues that directed their time 
and resources to other tasks, the integration of the screening protocol into the electronic 
medical records (EMR) system would alleviate the burden of the protocol on providers’ time. 
The possibility that the screening protocol would auto-populate patient specific information to 
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highlight at-risk patients would make screening patients more time-efficient for providers. Once 
the EMR extracts at-risk criteria of the patient, an integrated STOP-Bang questionnaire would 
allow providers’ to conveniently screen patients with results documented in the electronic 
medical record. By having the results of the screening directly documented in the EMR this 
would support providers referral for overnight polysomnography and ensure reimbursement 
eliminating the extra time necessary to document results supporting coverage by screening 
patients using hard copies of the protocol. The integration of the protocol into the EMR may 
eliminate the extra time burden required with the project protocol possibly further improving 
providers’ adherence to screening and ultimately leading to an increased number of patients 
referred for diagnostic testing and the number of confirmed OSA diagnosis.  
 Theory. The theory of planned change and JHNEBP model both facilitated the 
development and implementation of the project. The concepts of driving forces and restraining 
forces detailed by Lewin were displayed in providers desire to maintain compliance conflicting 
with the belief that unmanaged OSA was not a clinical priority and lack of time. The JHNEBP 
model provided a straightforward guide that navigated the project from creating a practice 
question, searching and appraising the evidence, to evaluating and disseminating the findings. 
Future projects aiming to increase detection of OSA and utilization of best-practice would be 
assisted with the use of these theories.  
 Research. Additional quality research related to the various concepts of screening for 
OSA in the primary care setting would prove invaluable. As highlighted through this project, 
nursing research exploring the correlation of providers’ knowledge and beliefs of OSA and 
frequency of screening, referral, and confirmation would provide useful insight and guide future 
interventions aiming at promoting detection of OSA. The advance practice nurse (APN) is in a 
favorable position to pioneer future research or evidence-based practice projects regarding 
detection of OSA in the primary care setting. 
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 Education. Principles from this EBP project and knowledge gained from project 
outcomes will have implications for nurse educators and advanced practice nurses (APN’s). As 
attention to OSA heightens and unmanaged OSA is associated with numerous health risks to 
patients, being aware of screening recommendations and methods will be instrumental to APN’s 
in primary care. Nurse educators and APN’s are both in pivotal positions to be well-versed in the 
importance of diagnosing and managing OSA and to educate both patients and other health 
care providers.   
Conclusion.  
 In summary, results from this EBP project support the use a of OSA screening protocol 
to promote providers’ adherence to evidence-based screening recommendations. A screening 
protocol that detailed which patients were at-risk for OSA that necessitated screening along with 
recommending the STOP-Bang questionnaire was implemented at an active family practice 
clinic. The intervention was determined to have a significant association increasing providers’ 
adherence to screening for OSA. Although the intervention demonstrated a significant 
difference, secondary outcomes revealed no significant difference in the number of patients 
referred for diagnostic testing or newly diagnosed with OSA as a result of the protocol limiting its 
clinical utility and significance. Despite insufficient clinical effects, the implementation of this 
EBP project replaced the project sites current manner of screening patients for OSA that did not 
reflect best-evidence. This project provides a method of increasing providers’ adherence to 
screening and increasing awareness of undetected OSA.  
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AASM: American Academy of Sleep Medicine 
AHI: Apnea-Hypopnea Index 
ASAA: American Sleep Apnea Association 
APN: Advanced Practice Nurse 
CINAHL: Cumulative Index to Nursing and Allied Health Literature  
CPAP: Continuous Positive Airway Pressure 
EBP: Evidence Based Practice 
EMR: Electronic Medical Record 
JBI: Joanna Briggs Institute 
OSA: Obstructive Sleep Apnea 
SBQ: STOP-Bang Questionnaire 
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Appendix A 
Screening for Obstructive Sleep Apnea Policy 
In effort to promote screening for Obstructive Sleep Apnea according to available best-practice 
evidence, the following protocol has been developed to serve as a guide to providers. 
1. At-risk patients: The following diagnoses are acknowledged to place patients as at-risk 
for OSA. Patients with at least one of these established diagnoses should be screened for 
OSA. Universal screening of OSA in patients without one of these established diagnoses 
is not supported. Diagnoses include obesity, congestive heart failure, atrial fibrillation, 
treatment resistant hypertension (blood pressure above goal despite adherence to 
antihypertensive regimen of 3 medications, or hypertension controlled by at least 4 
medications), coronary artery disease, impaired glucose tolerance or type 2 diabetes, 
nocturnal dysrhythmias, stroke, pulmonary hypertension, preoperative for bariatric 
surgery, or high-risk driving populations.  
2. To screen for OSA in a patient that is at-risk the STOP-Bang questionnaire is the optimal 
method to detect OSA. The STOP-Bang questionnaire stratifies patients’ risk for OSA 
into low, moderate, and high based on total scores. Patients that are classified as high-risk 
based on STOP-Bang questionnaire scores should be referred for definitive diagnostic 
testing for OSA.  
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Appendix B 
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Appendix C 
Providers’ Adherence Records Log 
Appt 
Date 
Patient 
Code 
Gender At-Risk 
Diagnosis 
Screening 
Performed? 
(yes/no) 
SBQ tool 
used to 
screen? 
(yes/no) 
SBQ 
score 
Referred 
for 
diagnostic 
testing? 
(yes/no) 
OSA 
diagnosis 
confirmed? 
(yes/no) 
Weekly 
Adherence 
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